Brief: Kaleido Biosciences To Present Updated Data Of Kb295 In Ulcerative Colitis At The 2022 Crohn’S And Colitis Congress

Kaleido Biosciences

21/01/2022 16:40

Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES TO PRESENT UPDATED DATA OF KB295 IN
ULCERATIVE COLITIS AT THE 2022 CROHN’S AND COLITIS CONGRESS

Source text for Eikon:  ID:nGNX3fPwrx 
Further company coverage:  KLDO.O